Many
people who take nucleoside/nucleotide antivirals for chronic hepatitis B can safely
discontinue treatment, although this usually does not lead to a cure,
researchers reported last week at the AASLD virtual Liver
Meeting.
Nucleoside/nucleotide
analogues such ...